Abcellera Biologics Inc
NASDAQ:ABCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Square Four Projects India Ltd
BSE:526532
|
IN |
Abcellera Biologics Inc
Inventory
Abcellera Biologics Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Inventory
$6.3m
|
CAGR 3-Years
62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovotech Inc
XTSX:IOT
|
Inventory
CA$149.9k
|
CAGR 3-Years
57%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
Abcellera Biologics Inc
Glance View
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.
See Also
What is Abcellera Biologics Inc's Inventory?
Inventory
6.3m
USD
Based on the financial report for Dec 31, 2025, Abcellera Biologics Inc's Inventory amounts to 6.3m USD.
What is Abcellera Biologics Inc's Inventory growth rate?
Inventory CAGR 3Y
62%
The average annual Inventory growth rates for Abcellera Biologics Inc have been 62% over the past three years .
